Skip Navigation

International Immunology 2007 19(9):1115-1122; doi:10.1093/intimm/dxm082
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oosten, L. E. M.
Right arrow Articles by Goulmy, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Oosten, L. E. M.
Right arrow Articles by Goulmy, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2007. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes

Liesbeth E. M. Oosten1,*, Danijela Koppers-Lalic2,*, Els Blokland1, Arend Mulder1, Maaike E. Ressing2, Tuna Mutis1,3, Astrid G. S. van Halteren1, Emmanuel J. H. J. Wiertz2 and Els Goulmy1

1 Department of Immunohematology and Blood Transfusion and
2 Department of Medical Microbiology, Leiden University Medical Center, Albinusdreef 2, 2300RC Leiden, The Netherlands
3 Present address: Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands

Correspondence to: L. E. M. Oosten; E-mail: l.e.m.oosten{at}lumc.nl

CTLs specific for hematopoietic system-restricted minor histocompatibility antigens (mHags) can serve as reagents for cellular adoptive immunotherapy after allogeneic stem cell transplantation (SCT). In the HLA-mismatched setting, CTLs specific for hematopoietic system-restricted mHags expressed solely by the non-self ‘allo’ HLA molecules could be used to treat relapse after HLA-mismatched SCT. The generation of mHag-specific allo-HLA-restricted CTLs requires antigen-presenting cells (APCs) expressing low numbers of endogenous peptides to avoid co-induction of undesired allo-HLA reactivities. In this study, we exploited viral evasion strategies to generate APCs expressing a controlled set of endogenous peptides. Herpesviruses persist lifelong following primary infection due to expression of viral gene products that hamper T-cell recognition of infected cells. The herpesvirus-derived proteins US6, ICP47 and UL49.5 down-regulate endogenous antigen presentation in human APCs via inhibition of the transporter associated with antigen processing. EBV-transformed B cell lines transduced with retroviral vectors encoding US6, ICP47 or UL49.5 exhibited a stable decrease in cell-surface HLA class I expression and were protected from lysis by mHag-specific CTLs. Exogenous addition of mHag peptide fully restored target cell recognition. UL49.5 showed the most pronounced inhibitory effect, reducing HLA class I expression and mHag-specific lysis up to 99%. UL49.5 also significantly diminished allo-HLA reactivities mediated by allo-HLA-specific CTLs. In conclusion, UL49.5 could be a powerful new tool to study and modulate endogenous antigen presentation.

Keywords: antigen presentation/processing, cytotoxicity, recombinant viral vectors


* These authors contributed equally to this study.

Transmitting editor: G. J. Hammerling

This article has been corrected to remove the word ‘hemagglutinin’ from between the words "(mHags)" and "HA-1 or HA-2" in the first sentence of the introduction. The following equation in the last paragraph of the ‘Flow cytometric analyses’ paragraph has been corrected to read: MFI = [mean fluorescence sample 1 - mean fluorescence of secondary control] + [mean fluorescence sample 2 - mean fluorescence of secondary control]/2

Received 16 November 2006, accepted 21 June 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.